HOME > ARCHIVE
ARCHIVE
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
January 27, 2003
- DIAGNOSTIC NEWS IN BRIEF
January 27, 2003
- Sales of Risperdal Going Well
January 27, 2003
- Takeda, Beth Israel Deaconess Medical Center to Collaborate on Metabolic Disease Research
January 27, 2003
- Dipyridamole Shows Lowest Bleeding Risk in Secondary Stroke Prevention
January 27, 2003
- Sales of Cancer Analgesic Durotep Patch Rising Fast: Janssen, Kyowa Hakko
January 27, 2003
- Takara Bio Strengthens Collaboration with Lynx Therapeutics
January 27, 2003
- Boehringer Ingelheim to Codevelop Anticancer Agents with Sagres Discovery
January 27, 2003
- GE Makers Must Be Self-reliant: EPMA President Sugiura
January 27, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
January 27, 2003
- Chugai, GSK, Novartis to Enhance Supply of Drugs for Influenza
January 27, 2003
- BUSINESS NEWS IN BRIEF
January 27, 2003
- Kyorin, Taisho: Switch OTC Versions of Amorolfine for Athlete's Foot
January 27, 2003
- Eisai, Mitsui Knowledge to Collaborate in Bioinformatics Field
January 27, 2003
- Gov't Urged to Take Further Action to Promote Self-medication
January 27, 2003
- Sales of Sumitomo's Antipsychotic Lullan Likely to Miss Target
January 27, 2003
- Married Women Aged 60 or Older Most Confident about Their Health
January 27, 2003
- JPMA Reinforces Function of OPIR
January 27, 2003
- JIRA to Prepare Vision for Imaging Device Industry
January 27, 2003
- OBITURARY
January 27, 2003
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
